Out of Specification and Atypical Results
An in-depth understanding of Out of Specification (OOS) and Atypical results in pharmaceutical quality control. It examines the definitions, significance, and causes of these results and the regulatory requirements for investigating them. The content outlines the structured investigation process, starting from laboratory assessment to wider, documented procedures, emphasizing the importance of finding an assignable cause, addressing potential laboratory and process errors, and taking corrective actions. Key regulatory standards, such as the FDA’s Barr Decision, are discussed to highlight industry expectations for scientifically defensible investigations and quality assurance.
Whether for onboarding or annual refresher training, this Module is seamlessly deployable on any LMS and can be tailored to your company’s exact needs.
Duration: 30 Mins
Grade: Core Library
Description
Learning Objectives:
Learner Benefits:
|
Module Features:
Animations |
---|
Keywords
- Analytical Testing
- Assignable Cause
- Atypical Results
- Barr Decision
- Investigation Process
- Laboratory Error
- Out of Specification (OOS)
- Process Error
- Quality Control
- Regulatory Compliance
- Standard Operating Procedure (SOP)